Five Risks to Consider in Dividend Investing

Investing in dividend stocks is a popular strategy among many investors. Dividend stocks offer investors a decent dividend yield in addition to any potential gains from price appreciation. So investors tend to gain twice since not only they get paid dividends quarterly or yearly or twice yearly but also the price gains. Since dividends are …

Continue reading ‘Five Risks to Consider in Dividend Investing’ »

On The Performance of Fortune’s ‘Buy-and-Forget’ Portfolio

Success with equity investing is not easy. Seemingly solid blue chips can crash any time for any number of reason. Similarly volatility in the markets can appear any time like we are seeing in the global markets in the past few weeks. Trying to time the market is also a fool’s game. So the best …

Continue reading ‘On The Performance of Fortune’s ‘Buy-and-Forget’ Portfolio’ »

Blackrock: Energy Stocks Are Cheap Now

Crude oil prices seem to have stabilized with Brent closing at $66.76 on Friday for Jan, 2019 delivery. The dramatic over 25% plunge in oil prices since the peak reached in early October caught many off-guard. While further declines are possible some investors may be wondering if now is the time to add some positions …

Continue reading ‘Blackrock: Energy Stocks Are Cheap Now’ »

US Stock Buybacks. vs. Dividends: Which One is Bigger?

US firms are increasingly spending more of their earnings on stock buybacks than dividend payments to shareholders. One of the main reason for this is that the tax rate on capital gains is lower than that of dividends for investors. Hence investors are content with companies buying their own stock than returning cash to them …

Continue reading ‘US Stock Buybacks. vs. Dividends: Which One is Bigger?’ »

Which Foreign Biotech and Healthcare Companies have Raised Capital in the US

The biotech and healthcare sector has been hot in the past few years. Almost every week new biotech IPOs are coming to the market and investor appetite for these stocks seems no sign of waning. According to a report by BNY Mellon, more than 150 foreign Biotech and Healthcare stocks are listed or traded on the …

Continue reading ‘Which Foreign Biotech and Healthcare Companies have Raised Capital in the US’ »